A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

• Status: Completed
• Trial end date: 2004-03-01

Summary

This study was performed to confirm that a single 2.0-g dose of azithromycin SR is at least as effective as 7 days of levofloxacin 500 mg/day in adults with acute exacerbation of chronic bronchitis Secondary objectives: To assess safety and the bacteriologic efficacy of both treatment regimens

• Phase: Phase 3

Details

• Lead Sponsor: Pfizer
• Treatments: Azithromycin; Levofloxacin; Ofloxacin